GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Quick Ratio

Cognetivity Neurosciences (Cognetivity Neurosciences) Quick Ratio : 0.02 (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Cognetivity Neurosciences's quick ratio for the quarter that ended in Oct. 2023 was 0.02.

Cognetivity Neurosciences has a quick ratio of 0.02. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Cognetivity Neurosciences's Quick Ratio or its related term are showing as below:

CGNSF' s Quick Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.58   Max: 16.64
Current: 0.02

During the past 7 years, Cognetivity Neurosciences's highest Quick Ratio was 16.64. The lowest was 0.02. And the median was 0.58.

CGNSF's Quick Ratio is ranked worse than
99.12% of 678 companies
in the Healthcare Providers & Services industry
Industry Median: 1.2 vs CGNSF: 0.02

Cognetivity Neurosciences Quick Ratio Historical Data

The historical data trend for Cognetivity Neurosciences's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Quick Ratio Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Quick Ratio
Get a 7-Day Free Trial 2.92 0.70 1.82 0.33 0.25

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 0.25 0.11 0.03 0.02

Competitive Comparison of Cognetivity Neurosciences's Quick Ratio

For the Health Information Services subindustry, Cognetivity Neurosciences's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Quick Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Quick Ratio falls into.



Cognetivity Neurosciences Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Cognetivity Neurosciences's Quick Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Quick Ratio (A: Jan. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1.98-0)/7.893
=0.25

Cognetivity Neurosciences's Quick Ratio for the quarter that ended in Oct. 2023 is calculated as

Quick Ratio (Q: Oct. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.221-0)/11.437
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Cognetivity Neurosciences Quick Ratio Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019